ea0070aep689 | Pituitary and Neuroendocrinology | ECE2020
Jawiarczyk-Przybyłowska Aleksandra
, Halupczok-Żyła Jowita
, Syrycka Joanna
, Rolla Małgorzata
, Zembska Agnieszka
, Kubicka Eliza
, Bolanowski Marek
Acromegaly is a rare disease, caused by an excessive secretion of growth hormone (GH), and consequently the insulin like growth factor 1 (IGF-1). Patients with acromegaly have an increased risk of fractures, which might be correlated with insufficient quality of bone. It is known that use of FRAX in acromegaly is not validated, however we do not have other useful tools to assess real risk for fractures. The new valuable tool in the assessment of bone structure is the trabecula...